+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Use of monoclonal antibodies to fibrinogen, fibrin and fibrin (ogen) degradation products in atherosclerosis



Use of monoclonal antibodies to fibrinogen, fibrin and fibrin (ogen) degradation products in atherosclerosis



NATO ASI series Series A Life sciences19(219): 189-197




(PDF emailed within 1 workday: $29.90)

Accession: 017609738

Download citation: RISBibTeXText


Related references

Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Use of monoclonal antibodies. Arteriosclerosis 9(1): 109-121, 1989

Distribution and identification of fibrinogen fibrin and degradation products in atherosclerosis by monoclonal antibodies. Thrombosis & Haemostasis: 82, 1987

The role of fibrinogen, fibrin and fibrin(ogen) degradation products (FDPs) in tumor progression. Contemporary Oncology 17(2): 113-119, 2013

Soluble fibrin (ethanol gelation test) and fibrin(ogen) degradation products in suspected thrombosis with reference to the 125I-fibrinogen uptake test for detection of thrombus formation. European Journal of Haematology 31(S39): 65-74, 1983

Fibrinogen, fibrin and fibrin degradation products in relation to atherosclerosis. Clinics in Haematology 15(2): 355-370, 1986

Effect of fibrin-fibrinogenolysis on the determination of the fibrinogen content and fibrin-fibrinogen degradation products (FDP) by means of the fibrin polymerization time (FPT test). Folia Haematologica 106(5-6): 967-970, 1979

Monoclonal antibodies for fibrin-fibrinogen degradation products. Nihon Ketsueki Gakkai Zasshi 50(3): 699-705, 1987

Ca binding of rat fibrinogen and fibrin(ogen) degradation products. Febs Letters 93(1): 177-180, 1978

Monoclonal antibodies against fibrinogen and fibrin and against their proteolytic degradation products. Casopis Lekaru Ceskych 129(43): 1349-1351, 1990

Monoclonal antibodies to different neo-epitopes on fibrinogen and fibrin degradation products. Blood Coagulation & Fibrinolysis 1(4-5): 447-452, 1990

Monoclonal antibodies to fibrinogen-fibrin degradation products which contain D-domain. Thrombosis Research 38(3): 297-302, 1985

Fibrinogen, fibrin(ogen) degradation products and fibrinopeptide A in pleural effusions. High turnover of fibrinogen in pleurisy. Scandinavian Journal of Respiratory Diseases 59(4): 210-215, 1978

Comparison of the potentiating effect of fibrinogen fibrinogen degradation products and fibrin degradation products on the amidolytic activity of the plasminogen strepto kinase complex improvement of plasminogen determination in biological samples by decreasing the influence of fibrin degradation products. Thrombosis & Haemostasis 50(1): 56, 1983

Effect of fibrinogen, fibrin and fibrin ogen degradation products on the tissue plasminogen activator and plasminogen activator inhibitor-1 expressions of vascular endothelial cells in coculture system. Zhonghua Xinxueguanbing Zazhi 36(1): 62-67, 2008

Effect of fibrinogen, fibrin and fibrin (ogen) degradation products on the tissue plasminogen activator and plasminogen activator inhibitor-1 expressions of vascular endothelial cells in coculture system. Zhonghua Xin Xue Guan Bing Za Zhi 36(1): 62-67, 2009